These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1680259)

  • 1. [Excretion of pyridinoline with urine in children with Ehlers-Danlos syndrome and Marfan's syndrome and the effect of beta blocker and complex vitamin therapy on it].
    Prozorovskaia NN; Kozlov EA; Luk'ianov SV; Rudakov SS; Prozorovskiĭ VN; Del'vig AA
    Vopr Med Khim; 1991; 37(2):66-9. PubMed ID: 1680259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of therapy with beta-adrenoblockers and vitamin complexes on indices of oxyproline excretion in various hereditary connective tissue diseases].
    Prozorovskaia NN; Glinianaia SV; Gerashchenko LP; Rudakov SS; Solonichenko VG
    Vopr Med Khim; 1988; 34(5):99-104. PubMed ID: 2905846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary excretion of hydroxyproline in funnel chest deformity].
    Prozorovskaia NN; Glinianaia SV; Del'vig AA; Rudakov SS; Vorontsov IuP
    Vopr Med Khim; 1987; 33(3):59-62. PubMed ID: 3630018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early diagnosis of progression of funnel chest in children].
    Rudakov SS; Verovskiĭ VA; Prozorovskaia NN; Razuvaev MK
    Ortop Travmatol Protez; 1990 Nov; (11):10-7. PubMed ID: 2095488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in human urinary O-hydroxylysyl glycoside levels and their relationship to collagen metabolism.
    Segrest JP; Cunningham LW
    J Clin Invest; 1970 Aug; 49(8):1497-509. PubMed ID: 5431661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on free amino acids in the urine of patients with ocular diseases. II. Hydroxyproline in the urine of the patients with Marfan's syndrome].
    Yamori K
    Nihon Ganka Kiyo; 1969 Jun; 20(6):600-6. PubMed ID: 5391145
    [No Abstract]   [Full Text] [Related]  

  • 7. [Simultaneous occurrence of Ehlers-Danlos syndrome and Marfan's syndrome].
    Fazekas A
    Orv Hetil; 1976 Jan; 117(3):154-8. PubMed ID: 1246406
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic disorders in children with developmental thoracic defects].
    Samsygin SA; Dolgina EN; Luk'ianov SV; Rudakov SS
    Khirurgiia (Mosk); 1990 Aug; (8):85-9. PubMed ID: 2259182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical management of Marfan's syndrome and ascending aortic aneurysms in France: initial assessment].
    Ladouceur M; Weber F; Morin P; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Feb; 99(2):117-22. PubMed ID: 16555694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of collagen-normalizing therapy on the incidence and severity of anesthetic and postoperative complications in children with connective tissue syndromes].
    Rudakov SS; Mikhel'son VA; Luk'ianov SV; Stepanenko SM; Prozorovskaia NN; Del'vig AA; Razuvaev MK
    Anesteziol Reanimatol; 1990; (3):16-20. PubMed ID: 2396760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Syringomas mongolism, Marfan's disease and Ehlers-Danlos' disease].
    Dupré A; Bonafé JL
    Ann Dermatol Venereol; 1977 Mar; 104(3):224-30. PubMed ID: 141234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI.
    Steinmann B; Eyre DR; Shao P
    Am J Hum Genet; 1995 Dec; 57(6):1505-8. PubMed ID: 8533783
    [No Abstract]   [Full Text] [Related]  

  • 13. Decrease in hydroxyproline excretion in a patient with Marfan's syndrome after methandrostenolone therapy.
    Jones CR; Van Itallie TB; Stevenson SS; Pigman WW
    JAMA; 1969 Mar; 207(11):2085-6. PubMed ID: 5818381
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
    Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
    Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Maternal mortality among women with Marfan syndrome or vascular Ehlers-Danlos syndrome in France, 2001-2012].
    Cheulot P; Saucedo M; Bouvier-Colle MH; Deneux Tharaux C; Kayem G;
    Gynecol Obstet Fertil Senol; 2019 Jan; 47(1):30-35. PubMed ID: 30497941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A contribution to the Ehlers-Danlos syndrome].
    Hirthe D; Lindenhayn K
    Padiatr Grenzgeb; 1967; 6(3):213-23. PubMed ID: 4230779
    [No Abstract]   [Full Text] [Related]  

  • 17. Different patterns of aortic wall elasticity in patients with Marfan syndrome: a noninvasive follow-up study.
    Baumgartner D; Baumgartner C; Schermer E; Engl G; Schweigmann U; Mátyás G; Steinmann B; Stein JI
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):811-9. PubMed ID: 17000292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical correction of early forms of funnel chest in children with Marfan's and Ehlers-Danlos syndromes].
    Rudakov SS; Verovskiĭ VA; Goritskaia TA
    Grud Serdechnososudistaia Khir; 1991 Apr; (4):40-4. PubMed ID: 2059503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Ehlers-Danlos and Marfan syndromes in young children].
    De Paepe A; Van den Bossche H; Mortier G; Matton M
    J Genet Hum; 1988 Jun; 36(3):247-53. PubMed ID: 3411305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical abnormalities in Ehlers-Danlos syndrome.
    Straus B; Tejaratchi N
    Arch Intern Med; 1966 Nov; 118(5):461-5. PubMed ID: 5922243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.